Will the meeting please come to order? I'm Neel Kumar, Chief Executive Officer of Bridge Biopharma. Along with my fellow directors and executive officers of the company, I'd like to welcome you to this special meeting of stockholders. We appreciate your attendance, your interest and most importantly, your support of BridgeBio. This special meeting with stockholders is being held pursuant to the bylaws of the company and the notice of special meeting and joint proxy statement and prospectus sent to all stockholders as of close of business on 12/08/2020, the record date.
Due to the public health impact of the coronavirus outbreak, the special meeting is being held by remote communication only in a virtual meeting format. Stockholders may submit questions that relate to the purpose of this meeting at any time during the meeting in the space provided on the meeting portal. After dealing with a few procedural matters, we will take up items to be acted upon. I'd now like to turn the meeting over to Brian Stevenson, who will be acting as Secretary of the Special Meeting to proceed with the formal business of the meeting as set forth in the Notice of Special Meeting and Joint Proxy Statement and Prospectus. Thank you, Neil.
My name is Brian Stevenson,
and I'm the Chief Financial Officer, Treasurer and Secretary of the company. The agenda for the meeting and the rules of conduct are located on the virtual meeting portal. In order to conduct an orderly meeting and give all eligible stockholders an opportunity to participate, we ask that participants abide by these rules. Cynthia Scoglins of Broadridge Financial Solutions Incorporated has been appointed to serve as the independent inspector of the election for this meeting. Ms.
Scoglund has executed the oath of office which will be filed with the minutes of this meeting. Broadridge has certified that mailing of the notice of meeting and related proxy materials with respect to this meeting commenced on 12/15/2020 to the company's stockholders as of the close of business on 12/08/2020, the record date for this special meeting. A copy of the affidavit will be filed with the minutes of this meeting. A complete list of holders of record of the company's common stock as of the close of business on 12/08/2020, the record date for this meeting who are eligible to vote at this meeting is available on the meeting website for inspection by any stockholder during this meeting. A copy of the list of stockholders will be filed with the minutes of the company.
Stockholders holding a total of 106,117,409 shares of the company's common stock representing 86.47% of the company's outstanding common stock are represented at this meeting. The number of shares of common stock issued and outstanding at the record date and entitled to vote was 122,715,631. In accordance with the laws of the State of Delaware and the company's bylaws, a quorum is present at this special meeting. Proper notice having been given, this meeting has therefore been properly convened. It is 02:03AM Pacific Time on 01/19/2021 and the polls for voting on all matters presented to a vote at this meeting are open.
All BridgeBio stockholders entitled to vote at this meeting have the ability to do so online through the meeting portal. If you are a stockholder entitled to vote and have not yet voted or if you want to change your previously cast vote, please do so via the meeting portal. Please remember that if you have already voted by proxy, your shares will be automatically voted in accordance with the instructions provided on your proxy card and it is not necessary to vote again. After voting has been completed on all matters on the agenda we will close the polls and the inspector of the election will provide his preliminary report. We'll move now to review the proposals.
The first proposal to come before the company's stockholders at this meeting is the share issuance proposal in which you are asking stockholders to approve the issuance of shares of the company's common stock upon the terms and subject to the conditions set forth in the agreement and plan of merger dated as of 10/05/2020 by and among Eidos Therapeutics Inc, BridgeBio, Globe Merger Sub one Inc and Globe Merger Sub two. The board has unanimously recommended that the company's stockholders vote for this proposal. Are there any questions or comments on the first proposal? Seeing none, we'll move on to the second proposal. The second proposal to come before the company's stockholders at this meeting is the adjournment proposal in which we're asking stockholders to approve the adjournment of this special meeting if necessary or appropriate to solicit additional proxies in the events there are not sufficient votes to approve the share issuance proposal.
Because there are sufficient votes to approve the share issuance proposal, the proposal to adjourn this meeting to a later date or dates to select additional proxies is moved and will not be voted on. The polls are about to close. So, if you have not yet voted, please do so. Since everyone has had the opportunity to vote, it's now 10:09AM Pacific Time. And the polls are closed.
Will the Inspector of Election please deliver her summary report?
Having examined all of the ballots filed with me, I report that proposal number one has received the affirmative vote of at least a majority of the votes cast and is therefore approved. Since a quorum was present and there were sufficient votes represented at this special meeting to approve proposal one, The proposed proposal regarding the adjournment of this meeting is moot and is not being presented.
We will file the final report of the inspector of election with the records of this meeting. We will report the final results of the voting in a current report on Form eight ks which will be filed with the SEC within four business days of this meeting. We will now respond to any appropriate questions submitted during the meeting. And there'll be no questions submitted during the meeting relevant to today's agenda. I want to thank you for attending today's meeting.
This now concludes today's conference. Thank you for joining, and have a pleasant